Home Newsletters Hepatic Cell News NAFLD Indirectly Impairs Antigen Specific CD8+ T Cell Immunity against Liver Cancer...

NAFLD Indirectly Impairs Antigen Specific CD8+ T Cell Immunity against Liver Cancer in Mice

0
Scientists generated a doxycycline inducible MHC-I and II antigen expressing HCC cell line which allowed them to investigate tumor antigen specific T cell response in two non-alcoholic fatty liver disease (NAFLD) mouse models.
[iScience]
7992332 {7992332:BBBBBBBB} apa 50 1 171387 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
AbstractFull ArticleGraphical Abstract
Exit mobile version